Evidence map›Paper›PMID 37702092›Full record

ArticleJournal of the American Heart Association2023

Association Between Onset of Type 2 Diabetes and Risk of Atrial Fibrillation in New Zealanders With Impaired Glucose Tolerance Over 25 Years.

Dahai Yu, Bingjie Qu, Uchechukwu Levi Osuagwu, Karen Pickering, John Baker, Richard Cutfield, Yamei Cai, Brandon J Orr-Walker, Gerhard Sundborn, Zhanzheng Zhao and 1 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Journal of the American Heart Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Dahai YuDepartment of Nephrology, The First Affiliated Hospital Zhengzhou University Zhengzhou China.ORCID 0000-0002-8449-7725
Bingjie QuDepartment of Nephrology, The First Affiliated Hospital Zhengzhou University Zhengzhou China.
Uchechukwu Levi OsuagwuTranslational Health Research Institute (THRI) Western Sydney University, Campbelltown Sydney Australia.ORCID 0000-0002-1727-6914
Karen PickeringDiabetes Foundation Aotearoa Otara New Zealand.ORCID 0009-0004-0322-6483
John BakerDiabetes Foundation Aotearoa Otara New Zealand.
Richard CutfieldDiabetes Foundation Aotearoa Otara New Zealand.ORCID 0000-0002-4171-059X
Yamei CaiDepartment of Nephrology, The First Affiliated Hospital Zhengzhou University Zhengzhou China.
Brandon J Orr-WalkerDiabetes Foundation Aotearoa Otara New Zealand.
Gerhard SundbornSection of Pacific Health The University of Auckland Auckland New Zealand.ORCID 0000-0001-7550-9096
Zhanzheng ZhaoDepartment of Nephrology, The First Affiliated Hospital Zhengzhou University Zhengzhou China.
David SimmonsDepartment of Nephrology, The First Affiliated Hospital Zhengzhou University Zhengzhou China.ORCID 0000-0003-0560-0761
First Affiliated Hospital of Zhengzhou University · CNCamden and Campbelltown Hospitals · AUCounties Manukau District Health Board · NZNew Zealand Association of Counsellors · NZUniversity of Auckland · NZWaitemata District Health Board · NZZhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The association between the onset of type 2 diabetes (T2D) and atrial fibrillation (AF) risk in individuals with impaired glucose tolerance (IGT) remains unclear. This study aimed to investigate the relationship between the incident onset of T2D and 5- and 10-year (after the landmark period) risks of AF in people with IGT identified in South and West Auckland primary care settings between 1994 and 2019. Methods and Results We compared AF risk in patients with IGT with and without newly diagnosed T2D within a 1- to 5-year exposure window. Tapered matching and landmark analysis (to address immortal bias) were used to control for confounding variables. The cohorts incorporated 785 patients who had T2D newly diagnosed within 5 years from enrollment (landmark date) and 15 079 patients without a T2D diagnosis. Patients progressing to T2D exhibited significantly higher 5-year (after the landmark period) AF risk (hazard ratio [HR], 1.34 [95% CI, 1.10-1.63]) and 10-year (after the landmark period) AF risk (HR, 1.28 [95% CI, 1.02-1.62]) compared with those without incident T2D. The association was more pronounced among men, older patients, socioeconomically deprived individuals, current smokers, those with higher metabolic measures, and lower renal function. New Zealand European ethnicity was associated with a lower 5- and 10-year risk of AF. Conclusions This study found a mediating effect of T2D on the risk of AF in a population with IGT in New Zealand. The development of risk scores and future replication studies can help identify and guide management of individuals with IGT at the highest risk of AF following incident T2D.

Indexed as

Atrial FibrillationDiabetes Mellitus, Type 2Glucose IntoleranceAustralasian PeopleFemaleHumansMaleNew Zealandatrial fibrillationimpaired glucose toleranceNew Zealandtype 2 diabetes

Identifiers

PMID37702092
PMCPMC10547295
OpenAlexW4386705112

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.